已收盤 02-06 16:00:00 美东时间
+0.230
+1.81%
CPI Card Group Inc. (NASDAQ:PMTS) ("CPI" or the "Company"), a payments technology company and leading provider of payment cards and related digital solutions, today announced that Tricor Pacific Capital Inc. (the "Tricor
2025-12-05 22:12
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
2025-11-11 10:49
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
2025-11-06 09:55
DA Davidson analyst Peter Heckmann maintains CPI Card (NASDAQ:PMTS) with a Buy and lowers the price target from $32 to $30.
2025-11-06 05:29
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据CPI Card业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **第三季度表现:** - 净销售额同比增长11%,主要由ArrowEye收购贡献,部分被预付费业务7%的下滑所抵消 - 借记卡和信用卡业务销售额增长16%,其中ArrowEye贡献1500万美元 - 毛利率从去年同期的35.8%下降至29.7% - 调整后EBITDA下降7%至2340万美元 - 净收入同比增长78%(主要因去年同期包含债务退休成本) - 前九个月经营现金流从去年同期的1670万美元增至1990万美元 - 前九个月自由现金流从去年同期的1250万美元大幅
2025-11-05 12:31
Collaboration bridges physical and digital payment landscape to help prevent gift card fraud, connecting physical, mobile, and online use through contactless prepaid payment cardsCPI Card Group Inc. (NASDAQ:PMTS), a
2025-10-30 02:42
今日重点评级关注:Brookline Capital:上调Intensity Therapeutics评级至"买入",目标价3美元;Chardan Capital:维持Taysha Gene Therapies"买入"评级,目标价从9美元升至10美元
2025-08-13 09:10
CPI Card (NASDAQ:PMTS) reported quarterly earnings of $0.50 per share which met the analyst consensus estimate. This is a 1.96 percent decrease over earnings of $0.51 per share from the same period last year. The
2025-08-08 19:08
Companies Reporting Before The Bell • BeOne Medicines (NASDAQ:ONC) is expected ...
2025-08-08 16:32